Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues

Cancer Research- United States

doi 10.1158/0008-5472.can-05-4300

Full Text

Abstract

Available in

Categories

Cancer Research

Date

April 15, 2006

Authors

Christine Erdmann

Arul M. Chinnaiyan

Sofia D. Merajver

Celina G. Kleer

Publisher

American Association for Cancer Research (AACR)

Related search

DNA Sequence Context as a Marker of CpG Methylation Instability in Normal and Cancer Tissues

Scientific Reports

Multidisciplinary

English

Immunohistochemistry as Surrogate Marker for Molecular Typing of Special Types of Breast Carcinomas

Journal of Evidence Based Medicine and Healthcare

English

Multiphoton Microscopy of Endogenous Fluorescence Differentiates Normal, Precancerous, and Cancerous Squamous Epithelial Tissues

Cancer Research

Cancer Research

English

Allele Imbalance or Loss of Heterozygosity in Normal-Appearing Breast Epithelium as a Novel Marker to Predict Future Breast Cancer

English

Expression of Stemness Genes in Primary Breast Cancer Tissues: The Role of SOX2 as a Prognostic Marker for Detection of Early Recurrence

English

High Expression of EZH2 as a Marker for the Differential Diagnosis of Malignant and Benign Myogenic Tumors

Scientific Reports

Multidisciplinary

English

EZH2 Is a Sensitive Marker of Malignancy in Salivary Gland Tumors

Diagnostic Pathology

Forensic Medicine

English

P33ING1b Methylation in Fecal DNA as a Molecular Screening Tool for Colorectal Cancer and Precancerous Lesions

Oncology Letters

Cancer Research

English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

English